Avalo Therapeutics Inc. (AVTX)
5.85
-0.74 (-11.23%)
At close: Apr 04, 2025, 3:59 PM
6.09
4.02%
After-hours: Apr 04, 2025, 05:45 PM EDT
Avalo Therapeutics Revenue
Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending December 31, 2024, Avalo Therapeutics generated $192K in revenue.
Revenue (ttm)
$441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
$19.17K
Employees
23
Market Cap
62.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 441K | -77.08% |
| Dec 31, 2023 | 1.92M | -89.34% |
| Dec 31, 2022 | 18.05M | +234.40% |
| Dec 31, 2021 | 5.4M | -19.42% |
| Dec 31, 2020 | 6.7M | n/a |